Zeng Cao

Tianjin Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.

Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.

Journal: Cancer biology & medicine

Published: March 02, 2026

A Retrospective Analysis of Primary Bone Marrow Lymphoma: Clinical Features and Prognostic Factors.

A Retrospective Analysis of Primary Bone Marrow Lymphoma: Clinical Features and Prognostic Factors.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: February 13, 2025

Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation.

Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation.

Journal: Scientific reports

Published: November 03, 2024

HRP2 regulating MICU1-mediated Ca2+ overload to dictate chemoresistance of multiple myeloma.

HRP2 regulating MICU1-mediated Ca2+ overload to dictate chemoresistance of multiple myeloma.

Journal: Neoplasia (New York, N.Y.)

Published: September 24, 2024

Clinical features and treatment of bone marrow metastasis.

Clinical features and treatment of bone marrow metastasis.

Journal: Oncology letters

Published: February 25, 2023

DUT enhances drug resistance to proteasome inhibitors via promoting mitochondrial function in multiple myeloma.

DUT enhances drug resistance to proteasome inhibitors via promoting mitochondrial function in multiple myeloma.

Journal: Carcinogenesis

Published: March 01, 2022

Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple Myeloma.

Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple Myeloma.

Journal: Frontiers in oncology

Published: September 30, 2021

The Correlation of Minimal Residual Disease with Prognosis in TCF3-PBX1+ Acute Lymphoblastic Leukemia in Children

The Correlation of Minimal Residual Disease with Prognosis in TCF3-PBX1+ Acute Lymphoblastic Leukemia in Children

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 07, 2020

Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients.

Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients.

Journal: Annals of hematology

Published: November 19, 2020

Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis.

Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: A systematic review and meta-analysis.

Journal: Journal of ethnopharmacology

Published: November 15, 2020

The clinical characteristics of autoimmune haemolytic anaemia/Evans syndrome patients with clonal immunoglobulin/T cell receptor gene rearrangement.

The clinical characteristics of autoimmune haemolytic anaemia/Evans syndrome patients with clonal immunoglobulin/T cell receptor gene rearrangement.

Journal: Autoimmunity

Published: September 14, 2020

Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency.

Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency.

Journal: Oncology letters

Published: August 18, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026